Emily Miller

Emily Miller

Editor
    Achievements
  • Coverage of U.S. drug prices published or cited by news organizations, including The Hill, Fox Business and United Press International
  • Society of Professional Journalists, Society for Technical Communication and The Alliance of Professional Health Advocates member
  • 2016 Florida Society of News Editors third place winner in Breaking News
    Experience
  • Sun Sentinel
  • Health in a Heartbeat - NPR.org
  • UF Health News
  • San Antonio Express-News
    Education
  • University of Florida - Journalism, Bachelor of Science
  • Centers for Disease Control and Prevention (CDC) Health Literacy, certificates

Emily Miller is Drugwatch’s editor. She has 7 years of professional journalism experience and 13 years of personal experience as a patient living with Crohn’s disease.

The Hill recently published her personal story about the high cost of prescription drugs in the U.S. Other media organizations, including Fox Business and United Press International, published her research and reporting on U.S. prescription drug prices. The consumer site Be Brain Fit has published Emily’s articles about Prilosec and dementia, and excessive dopamine and compulsive behaviors.

Emily Miller brings a unique perspective and passion to Drugwatch. She was diagnosed with a chronic illness as a child, and as part of her daily routine for more than a decade she unknowingly took some of the potentially risky drugs consumers can learn about on Drugwatch.

Emily understands how it’s easy to assume drugs are safe simply because they are FDA-approved. However, through her personal and professional experiences, she has learned that some drugs and medical devices can leave patients with life-altering consequences without proper warning. This is a fact that motivates her to help patients and their families stay informed when it comes to medical products and procedures.

Emily Miller banner

"As the editor of Drugwatch, I draw on my background as both a patient and a journalist to ensure my team of writers provides consumers with the latest and most accurate information on drugs, medical devices, procedures and related lawsuits."

Emily Miller — on Drugwatch

Emily began her professional career as a journalist while attending the University of Florida. She worked as an editorial and marketing assistant for Miami magazine and as the production assistant at The Brechner Center for Freedom of Information, a unit of the University of Florida College of Journalism and Communications. She also contributed to the campus newspaper, the Independent Florida Alligator.

Emily went on to work as a writer for UF Health News; an editor, producer and anchor for WUFT.org; and a correspondent for The Gainesville Sun. She worked for the Reporters Committee for Freedom of the Press in Washington, D.C., and the San Antonio Express-News in San Antonio, Texas.

Her assignments ranged from writing and editing news and feature stories about health topics to covering state and federal court proceedings, lawsuits and the U.S. Supreme Court during the time of the Affordable Care Act decision.

Emily also composed scripts for Health in a Heartbeat, a podcast on consumer-health information and the latest medical research news. It airs on public radio stations in more than 55 markets nationwide in addition to being available on NPR.org and the NPR One mobile app.

After graduating with a bachelor’s degree in journalism from UF, Emily covered crime, breaking news and local government for the South Florida Sun Sentinel. There, her passion for being an advocate and voice for victims only grew stronger, and in 2017, she joined Drugwatch.

Emily holds five Health Literacy certificates from the Centers for Disease Control and Prevention, including Health Literacy for Public Health Professionals; Writing for the Public; Creating Easier to Understand Lists, Charts and Graphs; Fundamentals of Communicating Risks; and Using Numbers and Explaining Risks.

She is a member of The Alliance of Professional Health Advocates, the American Association for the Advancement of Science, the Society of Professional Journalists and the Society for Technical Communication.

More Drugwatch Authors

Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(888) 645-1617

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.